APH vs RVPH · P/E 40, rev $16.38B vs $7.6M cap
Amphenol Corporation (APH) versus Reviva Pharmaceuticals Holdings Inc. (RVPH) — a side-by-side from cached financials, not a winner call.
Amphenol Corporation (APH) is a electronic components company listed on US.
Reviva Pharmaceuticals Holdings Inc. (RVPH) is a biotechnology company listed on NASDAQ.
Latest reported APH revenue for 2026-06-30 was $16.38B. Net income was $2.70B. APH currently screens at market cap $170.77B and trailing P/E 39.9.
RVPH does not have a complete income-statement cache yet.
APH currently screens at market cap $170.77B and trailing P/E 39.9. RVPH currently screens at market cap $7.6M.
Not investment advice. Open the APH and RVPH stock pages for the full models.
Not investment advice.